Related Experiment Videos
[Current data on epidermal Langerhans cells]
1Unité INSERM 346, Clinique Dermatologique, Pavillon R, Hôpital Edouard Herriot, Lyon, France.
Pathologie-Biologie
|October 1, 1994
Summary
Langerhans cells initiate immune responses by presenting antigens to lymphocytes. These specialized skin cells, originating from bone marrow, migrate to lymph nodes, playing a crucial role in immune surveillance and allergic reactions.
Area of Science:
- Immunology
- Dermatology
- Cell Biology
Context:
- Skin acts as both a target and initiator of self-immune reactions.
- Langerhans cells constitute 2-5% of epidermal cells and are key antigen-presenting cells (APCs).
- These cells originate from bone marrow and colonize skin and mucosa.
Purpose:
- To explore the role of Langerhans cells in immune responses and antigen presentation.
- To investigate the factors influencing Langerhans cell migration and immune function.
- To understand the in vitro and in vivo behavior of Langerhans cells.
Summary:
- Langerhans cells are unique epidermal cells that capture, process, and present antigens to lymphocytes, initiating immune responses.
- Tumor Necrosis Factor alpha (TNF-alpha) enhances the generation of Langerhans cells from CD34-positive precursors.
- In vitro studies show Langerhans cells mature into interdigitating cells, suggesting in vivo maturation during lymph node migration.
- Their migration to lymph nodes for T-cell sensitization was demonstrated in human contact dermatitis.
- Cellular interactions and soluble mediators like cytokines and neuropeptides may modulate Langerhans cell function.
Impact:
- Confirms the role of Langerhans cells in cutaneous surveillance and elimination of exogenous antigens.
- Highlights the potential for modulating Langerhans cell activity in immuno-allergic conditions.
- Suggests further research into factors controlling Langerhans cell migration and immune function.